Immuneering Corporation

NASDAQ:IMRX

1.45 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -61.037-53.472-50.514-33.536-17.04-7.709
Depreciation & Amortization 00.3520.7970.1590.0790.018
Deferred Income Tax 000-0.307-0.350.739
Stock Based Compensation 6.5015.7274.0641.8031.0870.597
Change In Working Capital -0.925-0.9751.7170.91.2530.437
Accounts Receivables 00.0120.2340.28-0.290.614
Inventory 000000.018
Accounts Payables -0.112-1.1071.76-0.131.1860.27
Other Working Capital -0.8130.12-0.2770.7510.358-0.465
Other Non Cash Items 0.461-0.602-0.1660.130.351.476
Operating Cash Flow -55-48.969-44.101-30.851-14.621-4.442
Investing Activities:
Investments In Property Plant And Equipment 0-0.343-0.742-0.061-0.053-0.021
Acquisitions Net 00-41.8310.0700
Purchases Of Investments 0-44.661-50.105-75.62600
Sales Maturities Of Investments 052.392.67875.61600
Other Investing Activites 26.435041.831-75.61600
Investing Cash Flow 26.4357.29641.831-75.616-0.053-0.021
Financing Activities:
Debt Repayment 000003.825
Common Stock Issued 4.23728.20.019120.31937.98217.228
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 5.3040.2410.01923.94637.9829.522
Financing Cash Flow 5.30428.4410.019144.26537.98217.172
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -23.261-13.231-2.25137.79823.30812.708
Cash At End Of Period 36.14559.40672.63774.88837.0913.782